Use of PKC inhibitors in transplantation

Details for Australian Patent Application No. 2011247881 (hide)

Owner Novartis AG

Inventors Korn, Alexander; Lake, Philip; Maibucher, Axel

Agent Davies Collison Cave

Pub. Number AU-A-2011247881

Parent 2007333313

Filing date 9 November 2011

Wipo publication date 1 December 2011

International Classifications

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

24 November 2011 Complete Application Filed

1 December 2011 Application Open to Public Inspection

  Published as AU-A-2011247881

13 September 2012 Section 223 Application Allowed

  Novartis AG The time in which to request examination has been extended to 22 Jun 2012 . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011247882-Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions

2011247880-Method and apparatus for restricting DVD content